Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
CAR-T
Biotech
Adicet Bio CAR-T sparks lupus remissions in early-stage trial
Adicet's prula-cel sent more than half of patients’ lupus into remission, without the dangerous side effects that recently rocked Big Pharma.
Darren Incorvaia
Sep 28, 2026 6:45am
Kyverna pubs 1-year miv-cel data as CAR-T peers hit safety snags
Sep 24, 2026 6:02am
Cellectis cans allogeneic CAR-Ts to hop aboard in vivo bandwagon
Sep 14, 2026 5:26am
BMS’ pivotal CAR-T multiple myeloma trial hits primary endpoint
Sep 8, 2026 9:11am
Novartis halts autoimmune CAR-T trials after 3 deaths
Aug 31, 2026 6:25pm
Fierce Pharma
Legend Biotech CEO resigns; search underway for replacement
Jul 27, 2026 9:32am
